glp-1 hurst tx Rejuv Juice GLP-1 Medications Clinic Near Me

Two further points are worth knowing: Hair loss appears on the Foundayo label, reported in roughly 45% of users versus 2% on placebo, and more often in women (about 7%) than men (under 1%)

FIGURE 2 Collectively, the evidence reviewed in this section supports the conclusion that appetite and behavioral peptide systems have been constrained more by conceptual caution than by biological inadequacy

1 2 "Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 26-29 January 2026"

GLP-1 medications remain a safe and effective option for managing type 2 diabetes and obesity for the majority of the population, but its crucial to evaluate each patients risk profile before starting treatment

The first head-to-head clinical trial (SURMOUNT-5, published in NEJM 2025) showed tirzepatide produced 20.2% average weight loss at 72 weeks versus 13.7% for semaglutide approximately 47% greater relative weight loss